VINCIARELLI PATRIZIO sold $212K of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 700 shares of VICOR CORP (VICR) at an average of $302.40 ($302.04–$303.32, $0.21M total) across 2 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jul 7, 2026, 2:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 7, 2026, 2:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

For trading, the key takeaway is the disclosed sale size and execution price range, with the mitigating factor that it was under a pre-arranged 10b5-1 plan.

02

Market read

Primarily a sentiment/positioning datapoint; absent other catalysts, it is unlikely to drive a major repricing.

03

What to watch

The article provides only the sale details; it does not include any concurrent buys, changes in guidance, or operational/regulatory developments that would make the transaction more decision-relevant.

Relevance 3/10Novelty 4/10Timing: SEC Form 4 filed 2026-07-07 for trades executed 2026-07-06

Background

The article is an SEC Form 4 insider transaction: Chairman & CEO sold shares in open-market trades executed 2026-07-06, filed 2026-07-07.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

Vinciarelli Patrizio, VICOR’s Chairman & CEO, sold 700 shares in open-market trades at ~$302.04–$303.32 per share on 2026-07-06 under a 10b5-1 plan.

Expected impact

Likely limited near-term price impact; any effect should be small and sentiment-driven rather than fundamental.

Evidence & confidence

The filing discloses the sale size, price range, and that it was executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider sales can still be read by some traders as a mild caution signal about near-term outlook.

Key entities

  • VICOR CORP

    US-listed company whose insider sale is disclosed via SEC Form 4.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and 10% owner who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.